Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center.

@article{Eastham2014TreatmentOF,
  title={Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center.},
  author={A Brooke Eastham and Alisa N. Femia and Abrar A. Qureshi and Ruth Ann Vleugels},
  journal={JAMA dermatology},
  year={2014},
  volume={150 1},
  pages={92-4}
}
Treatment Options for Pityriasis Rubra Pilaris Including Biologic Agents: A Retrospective Analysis From an Academic Medical Center Pityriasis rubra pilaris (PRP) is characterized by hyperkeratotic papules, palmoplantar keratoderma, and widespread erythema with islands of sparing. Treatment is challenging, and a standard therapeutic protocol does not exist. Given the paucity of available therapeutic data, we assessed the clinical presentation of PRP and clinical response (CR) to therapy at 2… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Management of refractory pityriasis rubra pilaris : challenges and solutions

Calcipotriol 25 Tazarotene
2017
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…